Oxidative stress and antioxidant therapy in Parkinson's disease
M Ebadi, SK Srinivasan, MD Baxi - Progress in neurobiology, 1996 - Elsevier
Parkinson's disease, known also as striatal dopamine deficiency syndrome, is a
degenerative disorder of the central nervous system characterized by akinesia, muscular …
degenerative disorder of the central nervous system characterized by akinesia, muscular …
[HTML][HTML] Pharmacological aspects of human and canine narcolepsy
S Nishino, E Mignot - Progress in neurobiology, 1997 - Elsevier
Narcolepsy-cataplexy is a disabling neurological disorder that affects 1 2000 individuals.
The main clinical features of narcolepsy, excessive daytime sleepiness and symptoms of …
The main clinical features of narcolepsy, excessive daytime sleepiness and symptoms of …
[图书][B] Sleep disorders medicine E-Book: Basic science, technical considerations, and clinical aspects
S Chokroverty - 2009 - books.google.com
Dr. Sudhansu Chokroverty—a world-recognized expert in sleep medicine—presents the
third edition of Sleep Disorders Medicine for the latest developments in this rapidly …
third edition of Sleep Disorders Medicine for the latest developments in this rapidly …
The new generation of monoamine oxidase inhibitors
S Mitsuhashi, T Kojima, N Nakanishi, T Fujimoto… - Progress in Drug …, 1992 - Springer
The development of monoamine oxidase (MAO) inhibitors has followed a winding path. At
the origin was the finding of EA Zeller that iproniazid, a hydrazine derivative designed to …
the origin was the finding of EA Zeller that iproniazid, a hydrazine derivative designed to …
Narcolepsy and its treatment with stimulants. ASDA standards of practice.
This review is part of the standards of practice recommendations. It has been commended
and reviewed by the Board of the ASDA. It reflects recommendations of the Board for the …
and reviewed by the Board of the ASDA. It reflects recommendations of the Board for the …
Clinical aspects and pathophysiology of narcolepsy
Y Dauvilliers, M Billiard, J Montplaisir - Clinical Neurophysiology, 2003 - Elsevier
Narcolepsy is a chronic debilitating sleep disorder first described in the late 19th century. It is
characterized by two major symptoms, excessive daytime sleepiness and cataplexy, and two …
characterized by two major symptoms, excessive daytime sleepiness and cataplexy, and two …
Practice parameters for the treatment of narcolepsy: an update for 2000
Standards of Practice Committee Littner Michael MD … - Sleep, 2001 - academic.oup.com
Successful treatment of narcolepsy requires an accurate diagnosis to exclude patients with
other sleep disorders, which have different treatments, and to avoid unnecessary …
other sleep disorders, which have different treatments, and to avoid unnecessary …
Narcolepsy: current treatment options and future approaches
M Billiard - Neuropsychiatric disease and treatment, 2008 - Taylor & Francis
The management of narcolepsy is presently at a turning point. Three main avenues are
considered in this review: 1) Two tendencies characterize the conventional treatment of …
considered in this review: 1) Two tendencies characterize the conventional treatment of …
Narcolepsy
MS Aldrich - New England Journal of Medicine, 1990 - Mass Medical Soc
NARCOLEPSY, a syndrome of excessive sleepiness and abnormalities of rapid-eye-
movement (REM) sleep, 1 is a distinct neurologic disorder with characteristic clinical …
movement (REM) sleep, 1 is a distinct neurologic disorder with characteristic clinical …
High-dose selegiline in treatment-resistant older depressive patients
T Sunderland, RM Cohen, S Molchan… - Archives of general …, 1994 - jamanetwork.com
Background: We examined the effect of high-dose selegiline in 16 treatment-resistant older
depressive patients. We hypothesized that selegiline, at a dosage of 60 mg/d, would be at …
depressive patients. We hypothesized that selegiline, at a dosage of 60 mg/d, would be at …